Boothbay Fund Management »

Aclaris Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.3M 197k 6.85
2023-06-30 $2.1M 204k 10.37
2023-03-31 $3.8M 474k 8.09
2021-06-30 $337k 19k 17.58
2021-03-31 $529k 21k 25.21
2020-12-31 $333k 52k 6.47
2019-09-30 $13k 12k 1.11
2017-09-30 $535k 21k 25.83
2017-06-30 $350k 13k 27.09
2017-03-31 $940k 32k 29.81
2016-12-31 $264k 9.7k 27.18